Effect of FGF23 in maintenance hemodialysis patients 1. Addition of novel biomarkers for predicting all-cause and cardiovascular mortality in prevalent hemodialysis patients 2. Oral iron supplementation with sodium ferrous citrate reduces the serum intact and c-terminal FGF23 levels of maintenance hemodialysis patients

維持透析患者におけるFGF23の影響 1.維持透析患者の新規バイオマーカー追加での全死亡死、心血管死予測 2.クエン酸第一鉄ナトリウムによる経口鉄補充は維持透析患者のiFGF23とcFGF23を低下させる

山下 和臣

英語

1. © 2017 The Authors. Therapeutic Apheresis and Dialysis published by John Wiley & Sons Australia, Ltd on behalf of International Society for Apheresis, Japanese Society for Apheresis, and Japanese Society for Dialysis Therapy. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

2. © 2016 The Authors Nephrology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Nephrology. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

1. Therapeutic Apheresis and Dialysis 2017; 22(1):31–39

2. Nephrology 22 (2017) 947–953

[DOI] https://doi.org/10.1111/1744-9987.12593

[DOI] https://doi.org/10.1111/nep.12909

広島大学